Literature DB >> 31930487

Pharmacometrics and Machine Learning Partner to Advance Clinical Data Analysis.

Gilbert Koch1, Marc Pfister1, Imant Daunhawer2, Melanie Wilbaux1, Sven Wellmann3, Julia E Vogt2.   

Abstract

Clinical pharmacology is a multidisciplinary data sciences field that utilizes mathematical and statistical methods to generate maximal knowledge from data. Pharmacometrics (PMX) is a well-recognized tool to characterize disease progression, pharmacokinetics, and risk factors. Because the amount of data produced keeps growing with increasing pace, the computational effort necessary for PMX models is also increasing. Additionally, computationally efficient methods, such as machine learning (ML) are becoming increasingly important in medicine. However, ML is currently not an integrated part of PMX, for various reasons. The goals of this article are to (i) provide an introduction to ML classification methods, (ii) provide examples for a ML classification analysis to identify covariates based on specific research questions, (iii) examine a clinically relevant example to investigate possible relationships of ML and PMX, and (iv) present a summary of ML and PMX tasks to develop clinical decision support tools.
© 2020 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Year:  2020        PMID: 31930487     DOI: 10.1002/cpt.1774

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  14 in total

1.  Introduction of an artificial neural network-based method for concentration-time predictions.

Authors:  Dominic Stefan Bräm; Neil Parrott; Lucy Hutchinson; Bernhard Steiert
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-05-18

2.  Drug Clearance in Neonates: A Combination of Population Pharmacokinetic Modelling and Machine Learning Approaches to Improve Individual Prediction.

Authors:  Bo-Hao Tang; Zheng Guan; Karel Allegaert; Yue-E Wu; Efthymios Manolis; Stephanie Leroux; Bu-Fan Yao; Hai-Yan Shi; Xiao Li; Xin Huang; Wen-Qi Wang; A-Dong Shen; Xiao-Ling Wang; Tian-You Wang; Chen Kou; Hai-Yan Xu; Yue Zhou; Yi Zheng; Guo-Xiang Hao; Bao-Ping Xu; Alison H Thomson; Edmund V Capparelli; Valerie Biran; Nicolas Simon; Bernd Meibohm; Yoke-Lin Lo; Remedios Marques; Jose-Esteban Peris; Irja Lutsar; Jumpei Saito; Jacobus Burggraaf; Evelyne Jacqz-Aigrain; John van den Anker; Wei Zhao
Journal:  Clin Pharmacokinet       Date:  2021-05-27       Impact factor: 5.577

3.  Application of Machine Learning for Tumor Growth Inhibition - Overall Survival Modeling Platform.

Authors:  Phyllis Chan; Xiaofei Zhou; Nina Wang; Qi Liu; René Bruno; Jin Y Jin
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-12-13

4.  Early predictions of response and survival from a tumor dynamics model in patients with recurrent, metastatic head and neck squamous cell carcinoma treated with immunotherapy.

Authors:  Ignacio González-García; Vadryn Pierre; Vincent F S Dubois; Nassim Morsli; Stuart Spencer; Paul G Baverel; Helen Moore
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-02-13

5.  Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumab.

Authors:  Nadia Terranova; Jonathan French; Haiqing Dai; Matthew Wiens; Akash Khandelwal; Ana Ruiz-Garcia; Juliane Manitz; Anja von Heydebreck; Mary Ruisi; Kevin Chin; Pascal Girard; Karthik Venkatakrishnan
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-01-19

6.  Contribution of machine learning to tumor growth inhibition modeling for hepatocellular carcinoma patients under Roblitinib (FGF401) drug treatment.

Authors:  Mélanie Wilbaux; David Demanse; Yi Gu; Astrid Jullion; Andrea Myers; Vasiliki Katsanou; Christophe Meille
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-06-21

7.  Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin.

Authors:  Lina Keutzer; Huifang You; Ali Farnoud; Joakim Nyberg; Sebastian G Wicha; Gareth Maher-Edwards; Georgios Vlasakakis; Gita Khalili Moghaddam; Elin M Svensson; Michael P Menden; Ulrika S H Simonsson
Journal:  Pharmaceutics       Date:  2022-07-22       Impact factor: 6.525

8.  Pharm-AutoML: An open-source, end-to-end automated machine learning package for clinical outcome prediction.

Authors:  Gengbo Liu; Dan Lu; James Lu
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-05-02

9.  Pharmacometrics meets statistics-A synergy for modern drug development.

Authors:  Yevgen Ryeznik; Oleksandr Sverdlov; Elin M Svensson; Grace Montepiedra; Andrew C Hooker; Weng Kee Wong
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-08-19

Review 10.  Artificial Intelligence in Infection Management in the ICU.

Authors:  Thomas De Corte; Sofie Van Hoecke; Jan De Waele
Journal:  Crit Care       Date:  2022-03-22       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.